![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
![[thumbnail of 14519oa.pdf]](https://edoc.mdc-berlin.de/style/images/fileicons/application_pdf.png) |
PDF
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
98kB |
| Item Type: | Article |
|---|---|
| Title: | Glucagonoma-induced acute heart failure |
| Creators Name: | Zhang, K., Lehner, L.J., Praeger, D., Baumann, G., Knebel, F., Quinkler, M. and Roepke, T.K. |
| Abstract: | Neuroendocrine tumours (NETs) represent a broad spectrum of tumours, of which the serotonin-producing carcinoid is the most common and has been shown to cause right ventricular heart failure. However, an association between heart failure and NETs other than carcinoid has not been established so far. In this case report, we describe a 51-year-old patient with a glucagon-producing NET of the pancreas who developed acute heart failure and even cardiogenic shock despite therapy. Heart failure eventually regressed after initialising i.v. treatment with the somatostatin analogue octreotide. Chromogranin A as a tumour marker was shown to be significantly elevated, and it decreased with clinical improvement of the patient. The effects of long-time stimulation of glucagon on the myocardium have not been studied yet; however, sarcoplasmic reticulum calcium leak can be discussed as a possible mechanism for glucagon-induced heart failure. |
| Source: | Endocrinology Diabetes and Metabolism Case Reports |
| ISSN: | 2052-0573 |
| Publisher: | BioScientifica |
| Volume: | 2014 |
| Page Range: | 140061 |
| Date: | 2014 |
| Official Publication: | https://doi.org/10.1530/EDM-14-0061 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
